Start Earlier, Move Faster: Smart Drug Development & Design From Candidate To Phase I
Today’s scientists are under significant time pressure to accelerate their compound from discovery to the clinic. Such pressure can often lead research organizations to adopt short-term thinking and overlook the downstream realities of drug development. Addressing issues early and comprehensively in the development life-cycle can result in fewer problems down the line such as escalating timelines, costs and regulatory issues. It is important to leverage the skills and experience of experts and connect the dots between competencies to optimize the development pathway and enable drug candidates to reach their true potential. Download a presentation outlining key considerations for transitioning including API and formulation development, pharmacokinetic and preclinical toxicology studies, and regulatory requirements.